Navigation Links
Electronic Brachytherapy a Viable Option for Early Stage Breast Cancer, According to Study Presented at ASCO Breast Cancer Symposium
Date:9/8/2008

Researcher Says, New Non-Isotope Based Delivery System Has Potential to Help Solve Radiation Therapy Access and Treatment Disparities Reported at

ASCO Symposium

WASHINGTON, Sept. 8 /PRNewswire/ -- Early clinical experience with the FDA cleared Axxent(R) Electronic Brachytherapy (eBx) System from Xoft demonstrates that the X-Ray-based, non-isotopic treatment is a viable option for adjuvant therapy for early-stage breast cancer. Initial data from this multi-center study was presented at the 2008 Breast Cancer Symposium here in Washington, DC. The phase IV study, "Early experience with an electronic brachytherapy technique for intracavitary accelerated partial breast irradiation," presented in poster discussion by Vivek Mehta, MD, Director, Center for Advanced Targeted Radiotherapies at Swedish Cancer Center in Seattle, was designed to evaluate the safety and device performance of electronic brachytherapy treatment using the Axxent System for early-stage breast cancer.

"While we will be monitoring these patients for the next five years, this data is very exciting as it confirms what we as investigators hoped it would from the start - that Electronic Brachytherapy is a safe and clinically promising alternative for accelerated partial breast irradiation," said Dr. Mehta, radiation oncology principal investigator for the study. "Because this method delivers therapy electronically, without the use of radioactive isotopes, it eliminates the need for the heavily-shielded vaults required by existing radiation therapy technologies. Radiation oncology centers now have a new solution for providing partial breast radiotherapy.

"Additionally, the study showed that patients were very satisfied with the treatment delivery and treatment course," added Dr. Mehta. "With electronic brachytherapy, unlike other forms of radiation therapy, the treatment team can stand behind a plexiglass shield but stay in the room with the patien
'/>"/>

SOURCE Xoft Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Diplomat Specialty Pharmacy Develops and Launches Best-In-Class Electronic Navigator (eNAV(TM)) Patient Care System
2. BioElectronics Announces Major Clinical Trials
3. BioElectronics Announces Profitability Breakeven and Additional Clinical Trials
4. First Breast Cancer Patient Receives Treatment in National Electronic Brachytherapy Registry Launched by Three Physician Societies
5. GSK Does Not Option XL784 for Further Development
6. Portrait(R) Plasma - A New Non-Surgical Option for one of the Most Requested Aesthetic Treatment - Aging Eyes
7. Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics
8. Roche Exercises its Option to Further Develop and Commercialize Memory Pharmaceuticals Nicotinic Alpha-7 Agonist, MEM 3454
9. New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma
10. ABC News NIGHTLINE Features HIFU with Sonablate(R) 500 as Non Invasive Treatment Option for Prostate Cancer
11. New AVAC Report on Pre-Exposure Prophylaxis Calls for Immediate Planning to Anticipate Study Results of Potential New HIV Prevention Option
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 2014 TODAY, AEGATE, the leader ... announced the appointment of Peter Fox as ... Channels and Partner Officer. Peter has served ... its acquisition by Oracle in 2011. Prior ... Geneva and subsequently Convergys, a world renowned ...
(Date:12/19/2014)... RATON, Fla. , Dec. 19, 2014 ... into a multi-product agreement with MSN Laboratories Pvt. Ltd. ... and MSN expect to commercialize several new ANDAs.  Under ... and supply the products exclusively to Breckenridge for the ... products under its label.  Breckenridge and MSN have agreed ...
(Date:12/19/2014)... -- Monarch America Inc. (OTCQB: CANK) ("Monarch America" or the ... this review of the Company,s recent achievements and strategic ... this past year, we achieved many of our early ... say that Monarch America is in a stronger and ... stated Eric Hagen , CEO of Monarch America ...
Breaking Medicine Technology:Aegate Appoints new CTO and Chief Channels & Partner Officer 2Aegate Appoints new CTO and Chief Channels & Partner Officer 3Aegate Appoints new CTO and Chief Channels & Partner Officer 4Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with MSN Laboratories Pvt. Ltd. 2Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 2Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 3
(Date:12/19/2014)... December 19, 2014 The ... to developing educational events, tools and resources for ... Cooking School , the world’s leading online cooking ... every human being needs: Culinary Rx. As an ... course, Culinary Rx, scheduled for debut spring 2015, ...
(Date:12/19/2014)... December 19, 2014 Eufaula, Oklahoma, located ... Lake Eufaula, the state’s largest lake with more than ... is home to a little more than 3,000 residents, ... on Saturday, the 6th of December. , Featuring Santa, ... through downtown Eufaula on Main Street. Narconon Arrowhead’s ...
(Date:12/19/2014)... The Medspa at Hendrick in Abilene, ... respected cosmetic brand Juvéderm. Voluma XC treats volume loss ... Medspa at Hendrick is pleased to be able to ... to its clients. , Voluma is the first and ... treat the mid-face and cheek area. This non-invasive treatment ...
(Date:12/19/2014)... Dec. 19, 2014 (HealthDay News) -- The intestinal bacteria ... and ulcerative colitis, may be inherited, researchers report. ... Medicine , could help in efforts to prevent the ... or colitis, the study authors added. "The intestinal ... young age can have a big impact on your ...
(Date:12/19/2014)... Dec. 19, 2014 (HealthDay News) -- Injectable drug users ... the suicide attempt rate of other substance users, a ... is associated with the risk of suicide attempt and ... University of Montreal, said in a university news release. ... We wanted to know who among substance users were ...
Breaking Medicine News(10 mins):Health News:The Plantrician Project and the Rouxbe Cooking School Join Forces to Develop Culinary Rx – a Plant-Prescription Course 2Health News:The Plantrician Project and the Rouxbe Cooking School Join Forces to Develop Culinary Rx – a Plant-Prescription Course 3Health News:The Plantrician Project and the Rouxbe Cooking School Join Forces to Develop Culinary Rx – a Plant-Prescription Course 4Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 2Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 3Health News:Breakthrough New Injectable Dermal Filler Voluma XC Offered by The MedSpa at Hendrick 2Health News:Crohn's, Colitis May Have Genetic Underpinnings, Study Finds 2Health News:Cocaine, Amphetamines May Up Injection Drug Users' Suicide Risk 2
... Offers Clinically Proven Effective Alternative to Controversial Over-the-Counter Cold ... common colds do not decrease as the ... of a new, naturally safe cold remedy, Zucol(TM) ( ... this prevalent virus, which actually strikes more during the ...
... see your full prescription medication history online and print ... tax season just around the corner, millions of Americans ... look for ways to get the most out of ... retail pharmacy, offers a simple way to get full ...
... MCA i1040XT, the new mobile clinical assistant (MCA), featuring touch screen ... and workflow of the clinical environment-- whether that is a hospital ... ... CA (PRWEB) March 4, 2009 -- TabletKiosk ®, a leader ...
... taking supplements often exceed recommended levels, study finds , , ... older Americans aren,t getting enough micronutrients such as calcium, ... an important role in maintaining health, a new study ... 6,200 people in four ethnic groups -- white, black, ...
... have also been accepted for publication as an original ... March 4 NewCardio, Inc. (OTC Bulletin Board: NWCI) ... Dr. Ihor Gussak, NewCardio,s Vice President and Chief Medical ... (ACC) 58th Annual Scientific Session in Orlando on March ...
... Calif., March 4 Based on its ... market, Frost & Sullivan presents OVATION Pharmaceuticals, ... & Sullivan Award for Entrepreneurial Company of ... success in achieving its growth objectives while ...
Cached Medicine News:Health News:Naturally Safe Zucol(TM) Brings Europe's Leading Cold Remedy to United States 2Health News:Naturally Safe Zucol(TM) Brings Europe's Leading Cold Remedy to United States 3Health News:Naturally Safe Zucol(TM) Brings Europe's Leading Cold Remedy to United States 4Health News:CVS/pharmacy Offers Free Prescription History Just in Time for Tax Season 2Health News:CVS/pharmacy Offers Free Prescription History Just in Time for Tax Season 3Health News:TabletKiosk Introduces the MediSlate™ MCA i1040XT: A Mobile Clinical Assistant (MCA) with Touch Screen Input 2Health News:TabletKiosk Introduces the MediSlate™ MCA i1040XT: A Mobile Clinical Assistant (MCA) with Touch Screen Input 3Health News:TabletKiosk Introduces the MediSlate™ MCA i1040XT: A Mobile Clinical Assistant (MCA) with Touch Screen Input 4Health News:TabletKiosk Introduces the MediSlate™ MCA i1040XT: A Mobile Clinical Assistant (MCA) with Touch Screen Input 5Health News:Older Americans May Lack Adequate Nutrition 2Health News:NewCardio Leadership to Present Clinical Data of Fully Automated QTinno(TM) Study at American College of Cardiology Annual Meeting 2Health News:NewCardio Leadership to Present Clinical Data of Fully Automated QTinno(TM) Study at American College of Cardiology Annual Meeting 3Health News:NewCardio Leadership to Present Clinical Data of Fully Automated QTinno(TM) Study at American College of Cardiology Annual Meeting 4Health News:Frost & Sullivan Lauds OVATION Pharmaceuticals for Its Business Model and Ability to Sustain Growth 2Health News:Frost & Sullivan Lauds OVATION Pharmaceuticals for Its Business Model and Ability to Sustain Growth 3Health News:Frost & Sullivan Lauds OVATION Pharmaceuticals for Its Business Model and Ability to Sustain Growth 4
... a polypeptide hormone secreted in significant amounts ... placenta. Prolactin, in synergy with estrogen, plays ... and maintenance of mammary gland growth and ... may have effects on cell growth in ...
... This Enzyme-Linked Immunosorbent Assay (ELISA) serves ... (RBP) from plasma, serum and,urine. In a ... the samples is bound to an,available excess ... is,immobilized to the surface of the microtitre ...
... ADVIA Centaur delivers a ... It provides the flexibility to ... system, now and in the ... a comprehensive disease-focused menu of ...
The Elisa test is used for the detection and semi-quantitative determination of IgG, antibodies to myeloperoxidase in human sera as an aid to the diagnosis is of microscopic polyangiitis....
Medicine Products: